Disparities in Survival and Tumor Characteristics in Patients With Single and Multiple Primary Merkel Cell Carcinomas

Melanoma and Skin Cancer

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Ann Dermatol Venereol

David C, Coquelle C, Le Corre Y, L'Orphelin JM, Nardin C, Aubin F, Cassecuel J, Dreno B, Wierzbiecka-Hainault E, Bens G, Beneton N, Dinulescu M, Kervarrec T, Saiag P, Blom A, Samimi M

doi: 10.1016/j.annder.2025.103411

Melanoma and Skin CancerImmunotherapy

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

J Am Acad Dermatol

Paulson KG, Park SY, Bhatia S, Hippe DS, Nghiem P

doi: 10.1016/j.jaad.2025.03.006

Melanoma and Skin Cancer

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

J Am Acad Dermatol

Andrew TW, Erdmann S, Alrawi M, Plummer R, Shalhout SZ, Sondak V, Brownell I, Lovat PE, Rose A

doi: 10.1016/j.jaad.2024.10.096

Melanoma and Skin Cancer

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

Br J Dermatol

Becker JC, Gesierich AH, Leiter U, Zimmer L, Hassel JC, von Wasielewski I, Ziemer M, Fluck M, Meier F, Spillner AN, Schilling B, Eigentler TK, Livingstone E, Ugurel S, Angela Y, Windemuth-Kieselbach C, Gutzmer R

doi: 10.1093/bjd/ljaf303

Melanoma and Skin Cancer

A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021

J Invest Dermatol

Tribble JT, Brownell I, Cahoon EK, Sargen MR, Shiels MS, Engels EA, Volesky-Avellaneda KD

doi: 10.1016/j.jid.2024.12.014

Melanoma and Skin Cancer

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Br J Dermatol

Laimer M, South AP, Mayr E, Kitzmueller S, Banner L, Alexander M, Hosler L, Yang H, Parris M, Arora M, Zimmermann G, Schweighofer-Zwink G, Bauer JW, Nikbakht N

doi: 10.1093/bjd/ljaf205

Further Publications Immunology

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

Acta Derm Venereol

Juan-Carpena G, Martínez Banaclocha N, Palazón Cabanes JC, Niveiro-de Jaime M, Betlloch Mas I, Blanes-Martínez M

doi: 10.2340/actadv.v105.42023

Melanoma and Skin Cancer

The use of Reflectance Confocal Microscopy to diagnose Basal Cell Carcinoma in the United Kingdom: A Prospective Observational Trial at a Single Centre

Br J Dermatol

Stevens HP, Pampena R, Farnetani F, Pellicani G, Angus C, El-Jabbour JN

doi: 10.1093/bjd/ljae356

Further Publications Immunology

Outcome of hematopoietic stem cell transplantation for SCID and impact of newborn screening on overall survival - A single referral center study

J Allergy Clin Immunol

Anchoo C, Lev A, Simon AJ, Levy S, Mandola A, Frizinsky S, Somekh I, Adeeb N, Adwan RSA, Toren A, Golan H, Bielorai B, Hutt D, Adam E, Somech R

doi: 10.1016/j.jaci.2025.01.029

Related content

Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trial

A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021

Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

The use of Reflectance Confocal Microscopy to diagnose Basal Cell Carcinoma in the United Kingdom: A Prospective Observational Trial at a Single Centre

Outcome of hematopoietic stem cell transplantation for SCID and impact of newborn screening on overall survival - A single referral center study